ARTELO BIOSCIENCES, INC.
About
Issuer
- Entity type
- Corporation
- Jurisdiction
- Nevada
- Sector
- Biotech
- Headquarters
- Solana Beach, CA
- Street
- 505 Lomas Santa Fe, Suite 160
- Zip
- 92075
Offering
- Total offering
- $237k
- Amount sold
- $237k
- First sale
- Mar 12, 2026
- Min investment
- $0
- Securities
- Debt
- Federal exemption
- Rule 506(b)
- Investors so far
- 1
How this filing compares
Ranked #17 of 23 Biotech filings in March 2026 by offering amount.
Median Biotech filing in March 2026: $5.4M. This offering is 0.0× the median.
Other California filings this week: 137 Holdings ISI, LLC, Am Tech Fund I LP, Be Bold Beverage, Inc., Calia 9 LLC, Coinbase Credit, Inc.
Leadership
Gregory D. Gorgas — Executive Officer (also: Director)
Connie Matsui — Director
Douglas Blayney — Director
Steven Kelly — Director
R. Martin Emanuele — Director
Tamara A. Favorito — Director
Gregory R. Reyes — Director
Mark Spring — Executive Officer (also: Director)
Filing details
ARTELO BIOSCIENCES, INC. filed a Form D with the SEC on March 27, 2026.